Literature DB >> 21821452

Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit.

María J González1, Alfonso P Gutiérrez, Rosa Gassió, María E Fusté, María A Vilaseca, Jaume Campistol.   

Abstract

OBJECTIVE: To investigate the relationship between neurological complications, neuroradiological findings, and behavioral problems, age at diagnosis and dietary control along the follow-up of the PKU patients in our metabolic unit.
DESIGN: Retrospective study of the PKU patients diagnosed and controlled in our unit from 1985 to 2010.
METHODS: Registry of patients in a database with 50 items filled in by review of the clinical histories. Statistical study of the data (SPSS, 19.0 version).
RESULTS: 121 patients were included (median age: 16.0, range 1 month-46 years). 76% of them were diagnosed through neonatal screening. 12.4% had mild-PKU, 19% moderate-PKU and 68.6% classic-PKU. 88.4% of patients were treated with a protein-restricted diet, and 11.6% with BH4. 97.7% of the early diagnosed patients had normal IQ, while 46.3% of late diagnosed patients had mental retardation, 28.5% were borderline and 25% had normal IQ. In early diagnosed patients, there was a significantly negative correlation between IQ [mean (SD) 100 (11.1)] and the index of dietary control during the first six years of life [median (range) 310 (105-992)] and that of the immediately past year [348 (106-1127)] (p < 0.0001). The proportion of patients with late diagnosis and neurological and behavioral problems was significantly higher than that of the early diagnosed ones (p < 0.001). The proportion of early diagnosed patients with neurological and behavioral problems who had good, intermediate or poor dietary control during the first 6 years of life and the immediately past year was significantly different (p < 0.001).
CONCLUSIONS: The results show the impact of early diagnosis and good dietary treatment on the IQ and on the percentage of neurological complications and behavioral problems in PKU patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821452     DOI: 10.1016/j.ymgme.2011.07.015

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Neurological improvement following reinstitution of a low phenylalanine diet after 20 years in established phenylketonuria.

Authors:  M S Anwar; B Waddell; J O'Riordan
Journal:  BMJ Case Rep       Date:  2013-07-12

2.  Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.

Authors:  Vanessa Trindade Bortoluzzi; Letícia Brust; Thales Preissler; Itiane Diehl de Franceschi; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

3.  Exploring the Barriers and Motivators to Dietary Adherence among Caregivers of Children with Disorders of Amino Acid Metabolism (AAMDs): A Qualitative Study.

Authors:  Jing Ying Lim; Roslee Rajikan; Noh Amit; Nazlena Mohamad Ali; Haslina Abdul Hamid; Huey Yin Leong; Maslina Mohamad; Bi Qi Koh; Aini Musa
Journal:  Nutrients       Date:  2022-06-18       Impact factor: 6.706

Review 4.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

5.  Voluntary Exercise Prevents Oxidative Stress in the Brain of Phenylketonuria Mice.

Authors:  Priscila Nicolao Mazzola; Vibeke Bruinenberg; Karen Anjema; Danique van Vliet; Carlos Severo Dutra-Filho; Francjan J van Spronsen; Eddy A van der Zee
Journal:  JIMD Rep       Date:  2015-10-07

Review 6.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

Review 7.  Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.

Authors:  Deborah A Bilder; J Kay Noel; Erin R Baker; William Irish; Yinpu Chen; Markus J Merilainen; Suyash Prasad; Barbara J Winslow
Journal:  Dev Neuropsychol       Date:  2016-11-02       Impact factor: 2.253

8.  Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years.

Authors:  Abdelrahim A Sadek; Mohammed H Hassan; Nesreen A Mohammed
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-05       Impact factor: 2.570

9.  An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.

Authors:  Kittiphong Thiboonboon; Pattara Leelahavarong; Duangrurdee Wattanasirichaigoon; Nithiwat Vatanavicharn; Pornswan Wasant; Vorasuk Shotelersuk; Suthipong Pangkanon; Chulaluck Kuptanon; Sumonta Chaisomchit; Yot Teerawattananon
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

10.  Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.

Authors:  Esther Imperlini; Stefania Orrù; Claudia Corbo; Aurora Daniele; Francesco Salvatore
Journal:  J Neurochem       Date:  2014-03-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.